Enzalutamide-Treated Prostate Cancer Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Enzalutamide-Treated Prostate Cancer
Enzalutamide-treated prostate cancer typically refers to advanced stages where the cancer has become resistant to standard hormone therapy and may have spread. Managing this condition involves complex, often expensive medications. TheDrugClub offers a valuable solution, helping members significantly reduce the cost of essential prescriptions like enzalutamide, making vital treatment more accessible and affordable.
Prostate cancer is a common malignancy among men, originating in the prostate gland. While often slow-growing, some forms can be aggressive and spread to other parts of the body. When prostate cancer progresses despite initial hormone therapy, it's often referred to as castration-resistant prostate cancer (CRPC). If it has also spread (metastasized), it's called metastatic castration-resistant prostate cancer (mCRPC).
What is Enzalutamide-Treated Prostate Cancer?
Enzalutamide (marketed as Xtandi) is an oral medication specifically designed to treat mCRPC. It belongs to a class of drugs called androgen receptor inhibitors. Prostate cancer cells often rely on male hormones (androgens) to grow. Even after therapies that reduce androgen levels, cancer cells can adapt and continue to grow by activating the androgen receptor. Enzalutamide works by blocking several steps in the androgen receptor signaling pathway, effectively starving the cancer cells of the signals they need to multiply. This can slow cancer progression and improve outcomes for patients.
Common Treatments and Medications
For mCRPC, treatment often involves a combination of therapies aimed at controlling the disease and managing symptoms. Beyond enzalutamide, other common medications and approaches include:
- Abiraterone (Zytiga): Another oral hormone therapy that inhibits androgen production throughout the body.
- Chemotherapy: Drugs like docetaxel or cabazitaxel may be used, particularly if other treatments are no longer effective.
- Radium-223 (Xofigo): A radioactive pharmaceutical used to treat bone metastases.
- Sipuleucel-T (Provenge): A personalized cellular immunotherapy that stimulates the immune system to attack prostate cancer cells.
- PARP inhibitors: For patients with specific genetic mutations, drugs like olaparib (Lynparza) or rucaparib (Rubraca) may be an option.
These medications are critical for managing advanced prostate cancer, but they are also notoriously expensive, often costing thousands of dollars per month, even with insurance. This financial burden can be a significant barrier to consistent treatment.
How TheDrugClub Members Save on Prescriptions
At TheDrugClub, we understand the financial strain that high
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.